Status:

COMPLETED

Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism

Lead Sponsor:

Brigham and Women's Hospital

Collaborating Sponsors:

Sanofi

Conditions:

Deep Vein Thrombosis

Pulmonary Embolism

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

To investigate the efficacy and safety of once daily enoxaparin as a "bridge" to warfarin for the outpatient treatment of acute deep venous thrombosis or pulmonary embolism.

Detailed Description

Background and Significance: Low molecular weight heparin (LMWH) as a "bridge" to warfarin has become the standard of care for outpatient treatment of acute deep venous thrombosis (DVT). LMWH is also...

Eligibility Criteria

Inclusion

  • Symptomatic acute deep venous thrombosis and/or pulmonary embolism confirmed by venous ultrasound and/or CT scan.
  • Pulmonary embolism patients with normal right ventricular size on chest CT scan.
  • Age greater than 18 years
  • Anticipated discharge within 72 hours of admission
  • Written informed consent

Exclusion

  • Pregnancy or intend to become pregnant
  • Patients requiring ongoing hospitalization \> 72 hours
  • Hypersensitivity to heparin, pork products or enoxaparin
  • Creatinine \> 2.0 mg/dl
  • Recurrent DVT and/or PE with oral anticoagulation
  • Surgery or medical procedure planned during the study that may pose a significant bleeding risk
  • Prior history of heparin-induced thrombocytopenia
  • Inability to participate for follow up appointments and study visits
  • Life expectancy \< 30 days
  • High risk of bleeding:
  • Active major bleeding within 30 days by GUSTO criteria
  • History of intracranial bleeding
  • Major surgery or trauma within 10 days
  • Head injury requiring hospitalization within 1 year
  • Intracranial tumor
  • Neurosurgery or non-cataract ophthalmologic surgery within 1 month
  • Thrombocytopenia

Key Trial Info

Start Date :

May 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2008

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00413374

Start Date

May 1 2006

End Date

December 1 2008

Last Update

June 28 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism | DecenTrialz